Mass Spectrometry In-Depth Focus 2015
Posted: 3 December 2015 | Claire Strain-Damerell (Structural Genomics Consortium), Michelle Hill (University of Queensland), Nicola Burgess-Brown (Structural Genomics Consortium), Pravin Mahajan (Structural Genomics Consortium), Rod Chalk (Structural Genomics Consortium) | No comments yet
In this Mass Spectrometry In-Depth Focus: Michelle M. Hill from University of Queensland discusses Mass spectrometric and systems biology approaches in drug target discovery, and Nicola Burgess-Brown, Rod Chalk, Claire Strain-Damerell and Pravin Mahajan from the Structural Genomics Consortium look at analysing recombinant proteins by mass spectrometry…
This Mass Spectrometry In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Analysis, Drug Discovery, Genomics, Mass Spectrometry
Related organisations
Queensland University, Structural Genomics Consortium (SGC)
Related people
Claire Strain-Damerell, Michelle Hill, Nicola Burgess-Brown, Pravin Mahajan, Rod Chalk
